[
  {
    "ts": null,
    "headline": "Dividend Growth Investing Is Breaking",
    "summary": "Dividend yields are rising, but the real danger is lurking beneath the surface. Read the full analysis here.",
    "url": "https://finnhub.io/api/news?id=a307a4b8cea510f6bf09e0786a025d35bb762c55e31f19190383355033eaa060",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767683100,
      "headline": "Dividend Growth Investing Is Breaking",
      "id": 137999186,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166443569/image_2166443569.jpg?io=getty-c-w1536",
      "related": "CLX",
      "source": "SeekingAlpha",
      "summary": "Dividend yields are rising, but the real danger is lurking beneath the surface. Read the full analysis here.",
      "url": "https://finnhub.io/api/news?id=a307a4b8cea510f6bf09e0786a025d35bb762c55e31f19190383355033eaa060"
    }
  },
  {
    "ts": null,
    "headline": "What Analysts Think Is Resetting The Story For Clorox (CLX)",
    "summary": "The latest update on Clorox trims the modelled fair value estimate slightly, from US$124.59 to US$122.41, as analysts factor in softer revenue growth assumptions of 1.39% versus 1.43% previously. This small adjustment reflects a tug of war between cautious views, tied to weaker Q1 results and a lower end EPS outlook, and more constructive voices who see reset expectations and clustered targets in the low to mid US$120s as a sign that the story is being recalibrated rather than abandoned. Stay...",
    "url": "https://finnhub.io/api/news?id=f9eafbb2254c0cbcfa4672a56e5fdf9bf277db49579a9cef16a697ee151c6956",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767669204,
      "headline": "What Analysts Think Is Resetting The Story For Clorox (CLX)",
      "id": 137997806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CLX",
      "source": "Yahoo",
      "summary": "The latest update on Clorox trims the modelled fair value estimate slightly, from US$124.59 to US$122.41, as analysts factor in softer revenue growth assumptions of 1.39% versus 1.43% previously. This small adjustment reflects a tug of war between cautious views, tied to weaker Q1 results and a lower end EPS outlook, and more constructive voices who see reset expectations and clustered targets in the low to mid US$120s as a sign that the story is being recalibrated rather than abandoned. Stay...",
      "url": "https://finnhub.io/api/news?id=f9eafbb2254c0cbcfa4672a56e5fdf9bf277db49579a9cef16a697ee151c6956"
    }
  }
]